Medication info
Menova Tablet (Acyclovir)

Menova Tablet (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Light blue round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199400172 · Notified 1994.08.16 · Insurance code 645901350

Summary

Main use
Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; for recurrent infections, administer at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg per dose 2 ~ 3 times daily after confirming efficacy. 3) To assess the natural course of the disease, treatment should be periodically discontinued for assessment every 6 ~ 12 months in patients receiving long-term therapy. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding sleeping hours, for a total of 7 days. 2) Consider intravenous administration in patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; earlier treatment produces better results. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, for example by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with a creatinine clearance less than 10 mL/min, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with a creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: As for adults. 2) Under 2 years: Administer 1/2 the adult dose. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg/kg body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older

  • Genital herpes
  • herpes simplex virus infections of the skin and mucous membranes
  • shingles virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat and prevent herpes simplex virus infections affecting the skin and mucous membranes, including genital herpes. It is also effective in treating shingles virus infections, particularly in alleviating acute pain. However, its effect on postherpetic neuralgia has not yet been proven. This medication is used for the treatment of chickenpox in children over 2 years old, thus assisting in the management of various viral infections. The medication is available in the form of tablets, syrup, and suspension, allowing for selection based on patient circumstances. Overall, it is used effectively for the treatment and prevention of viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; for recurrent infections, administer at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in immunocompetent patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg per dose 2 ~ 3 times daily after confirming efficacy. 3) To assess the natural course of the disease, treatment should be periodically discontinued for assessment every 6 ~ 12 months in patients receiving long-term therapy. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding sleeping hours, for a total of 7 days. 2) Consider intravenous administration in patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; earlier treatment produces better results. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, for example by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with a creatinine clearance less than 10 mL/min, it is preferable to reduce the dose to 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with a creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: As for adults. 2) Under 2 years: Administer 1/2 the adult dose. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg/kg body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Precautions

This medication should not be used in patients who have had allergic reactions to this medication or its ingredients. Caution is needed when using this medication in patients with poor kidney function, as neurological symptoms may occur more easily. Patients with impaired liver function should be carefully administered this medication due to the risk of further worsening liver function. Caution is advised when using this medication in young children, especially infants and toddlers, and it is recommended to administer it in the minimum necessary amounts. Elderly patients may have reduced kidney function, which can lead to increased concentration of this medication and more frequent adverse reactions, so dosage and administration intervals should be adjusted and used cautiously. Severe allergic reactions such as anaphylactic shock can occur infrequently while using this medication, so use should be discontinued immediately and medical attention sought if symptoms such as hypotension, difficulty breathing, and chest tightness occur. Dermatological reactions may include rashes, fever, blisters, and urticaria, so if these symptoms occur, discontinuation of the medication and consultation with a physician is necessary. Severe skin diseases such as Stevens-Johnson syndrome or toxic epidermal necrolysis may occur rarely, and careful observation of the skin condition is necessary. Neurological symptoms may include altered consciousness, confusion, hallucinations, seizures, drowsiness, and anxiety, especially in the elderly or patients with kidney impairment. Kidney function can be affected, so if there are abnormalities in urination or symptoms of hematuria or proteinuria occur, it is essential to inform a doctor immediately. Blood-related issues such as leukopenia, anemia, and bleeding can occur, making regular blood tests necessary. Symptoms of liver dysfunction such as jaundice or hepatitis should be monitored regularly to check liver health. Gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain may occur, and if symptoms are severe, the medication should be discontinued and medical personnel consulted. Adequate fluid intake should be maintained to prevent dehydration and reduce the burden on the kidneys while taking this medication. To enhance treatment effectiveness, it is important to start taking this medication as soon as possible from the onset of symptoms. Women who are pregnant or may become pregnant should carefully consider the risks to the fetus when using this medication, and those who are breastfeeding should discontinue nursing, as this medication may be excreted in breast milk. Overdosing on this medication can result in severe neurological symptoms and kidney damage, so proper dosage should be strictly adhered to, and any unusual symptoms should be reported to medical personnel immediately. This medication may interact with other drugs, so if other medications are being taken, it is important to inform a doctor or pharmacist. Caution should be exercised when engaging in activities that require attention, such as driving or operating machinery, as symptoms like altered consciousness or drowsiness may occur.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • respiratory distress
  • chest tightness
  • phototoxic reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 118 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • anxiety
  • coordination impairment
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • talking to oneself
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • low blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorder
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • convulsions
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container, as it may be sensitive to air and moisture. It should also be kept in a cool, dry place at or below 25 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.